Alkem Laboratories Limited

NSEI:ALKEM 株式レポート

時価総額:₹659.4b

Alkem Laboratories マネジメント

マネジメント 基準チェック /14

現在、CEO に関する十分な情報がありません。

主要情報

Vikas Gupta

最高経営責任者

n/a

報酬総額

CEO給与比率n/a
CEO在任期間1.2yrs
CEOの所有権n/a
経営陣の平均在職期間1.2yrs
取締役会の平均在任期間7.2yrs

経営陣の近況

Recent updates

Alkem Laboratories Limited Recorded A 5.4% Miss On Revenue: Analysts Are Revisiting Their Models

Nov 16
Alkem Laboratories Limited Recorded A 5.4% Miss On Revenue: Analysts Are Revisiting Their Models

Here's Why We Think Alkem Laboratories (NSE:ALKEM) Is Well Worth Watching

Nov 15
Here's Why We Think Alkem Laboratories (NSE:ALKEM) Is Well Worth Watching

What Alkem Laboratories Limited's (NSE:ALKEM) P/E Is Not Telling You

Sep 24
What Alkem Laboratories Limited's (NSE:ALKEM) P/E Is Not Telling You

Is Alkem Laboratories (NSE:ALKEM) Using Too Much Debt?

Sep 03
Is Alkem Laboratories (NSE:ALKEM) Using Too Much Debt?

Earnings Beat: Alkem Laboratories Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Aug 13
Earnings Beat: Alkem Laboratories Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year

Jul 27
Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year

Alkem Laboratories' (NSE:ALKEM) Dividend Will Be Reduced To ₹5.00

Jul 13
Alkem Laboratories' (NSE:ALKEM) Dividend Will Be Reduced To ₹5.00

Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year

Jun 27
Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year

Alkem Laboratories (NSE:ALKEM) Has Announced That Its Dividend Will Be Reduced To ₹5.00

Jun 13
Alkem Laboratories (NSE:ALKEM) Has Announced That Its Dividend Will Be Reduced To ₹5.00

Alkem Laboratories Limited (NSE:ALKEM) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?

Jun 01
Alkem Laboratories Limited (NSE:ALKEM) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?

Earnings Tell The Story For Alkem Laboratories Limited (NSE:ALKEM)

May 22
Earnings Tell The Story For Alkem Laboratories Limited (NSE:ALKEM)

Alkem Laboratories Limited (NSE:ALKEM) Just Reported And Analysts Have Been Lifting Their Price Targets

Feb 13
Alkem Laboratories Limited (NSE:ALKEM) Just Reported And Analysts Have Been Lifting Their Price Targets

Investors Appear Satisfied With Alkem Laboratories Limited's (NSE:ALKEM) Prospects

Jan 17
Investors Appear Satisfied With Alkem Laboratories Limited's (NSE:ALKEM) Prospects

We Think Alkem Laboratories (NSE:ALKEM) Can Manage Its Debt With Ease

Dec 27
We Think Alkem Laboratories (NSE:ALKEM) Can Manage Its Debt With Ease

Is Alkem Laboratories (NSE:ALKEM) Using Too Much Debt?

Sep 14
Is Alkem Laboratories (NSE:ALKEM) Using Too Much Debt?

Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year

Aug 02
Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year

Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year

Jul 07
Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year

Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year

May 22
Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year

We Think Alkem Laboratories (NSE:ALKEM) Can Stay On Top Of Its Debt

Mar 27
We Think Alkem Laboratories (NSE:ALKEM) Can Stay On Top Of Its Debt

Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?

Dec 26
Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?

These 4 Measures Indicate That Alkem Laboratories (NSE:ALKEM) Is Using Debt Reasonably Well

Sep 20
These 4 Measures Indicate That Alkem Laboratories (NSE:ALKEM) Is Using Debt Reasonably Well

Alkem Laboratories' (NSE:ALKEM) Dividend Is Being Reduced To ₹4.00

Jul 27
Alkem Laboratories' (NSE:ALKEM) Dividend Is Being Reduced To ₹4.00

Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year

Jul 13
Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year

Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?

Jun 11
Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?

Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?

May 23
Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?

Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?

Mar 06
Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?

Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?

Feb 21
Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?

CEO(最高経営責任者

Vikas Gupta

1.2yrs

在職期間

Dr. Vikas Gupta is Chief Executive Officer of Alkem Laboratories Limited from September 22, 2023. He has experience in Pharmaceutical Sector and brings with him deep experience across therapeutic areas inc...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Basudeo Singh
Executive Chairman51.3yrs₹200.60m13.31%
₹ 87.8b
Sarvesh Singh
VP of Sales & Marketing and Executive Directorno data₹44.50m0%
₹ 0
Sandeep Singh
MD & Executive Director1.2yrs₹81.50m0.0065%
₹ 43.1m
Mritunjay Singh
Executive Directorno data₹104.30m8.58%
₹ 56.6b
Srinivas Singh
Executive Director2.2yrs₹96.60m0.086%
₹ 566.4m
Madhurima Singh
Executive Directorno data₹104.10m8.77%
₹ 57.8b
Vikas Gupta
Chief Executive Officer1.2yrsデータなしデータなし
Akhilesh Sharma
President & Chief Medical Officerno dataデータなしデータなし
Kaustav Banerjee
President & Head Medtech Businessless than a yearデータなしデータなし
Rajorshi Ganguli
President & Global HR Headno dataデータなしデータなし
Nitin Agrawal
CFO & President of Financeless than a yearデータなしデータなし
Satish Singh
Head of Operationsno dataデータなし0.060%
₹ 396.7m

1.2yrs

平均在職期間

55yo

平均年齢

経験豊富な経営陣: ALKEMの経営陣は 経験豊富 とはみなされません ( 1.2年の平均在職年数)。これは新しいチームを示唆しています。


取締役

名称ポジション在職期間報酬所有権
Basudeo Singh
Executive Chairman51.3yrs₹200.60m13.31%
₹ 87.8b
Sarvesh Singh
VP of Sales & Marketing and Executive Director5yrs₹44.50m0%
₹ 0
Sandeep Singh
MD & Executive Director11.3yrs₹81.50m0.0065%
₹ 43.1m
Mritunjay Singh
Executive Director16yrs₹104.30m8.58%
₹ 56.6b
Srinivas Singh
Executive Director2.2yrs₹96.60m0.086%
₹ 566.4m
Madhurima Singh
Executive Director2.9yrs₹104.10m8.77%
₹ 57.8b
Arun Purwar
Independent Director9.7yrs₹3.30mデータなし
Sudha Ravi
Independent Director9.4yrs₹3.10mデータなし
Sangeeta Singh
Independent Director9.4yrs₹3.00mデータなし
Narendra Aneja
Independent Director4.7yrs₹3.20mデータなし
Rajeev Kher
Independent Directorless than a yearデータなしデータなし
Sujjain Talwar
Independent Director2.3yrs₹2.70mデータなし

7.2yrs

平均在職期間

62yo

平均年齢

経験豊富なボード: ALKEMの 取締役会経験豊富 であると考えられます ( 7.2年の平均在任期間)。